Comparison of the Idylla™ MSI assay with the Promega™ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study

[1]  A. Ristimäki,et al.  Detection of microsatellite instability with Idylla MSI assay in colorectal and endometrial cancer , 2021, Virchows Archiv.

[2]  T. Buhl,et al.  Managing Difficulties of Microsatellite Instability Testing in Endometrial Cancer-Limitations and Advantages of Four Different PCR-Based Approaches , 2021, Cancers.

[3]  K. Claes,et al.  Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer , 2021, Scientific Reports.

[4]  Cyrus Chargari,et al.  ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma , 2020, International Journal of Gynecological Cancer.

[5]  P. Goodfellow,et al.  Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients. , 2020, Gynecologic oncology.

[6]  A. Leroux,et al.  Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers , 2020, Scientific Reports.

[7]  J. Calderaro,et al.  Detection of microsatellite instability in a panel of solid tumours with the Idylla MSI Test using extracted DNA , 2020, Journal of Clinical Pathology.

[8]  G. Broeckx,et al.  Clinical performance of the Idylla MSI Test for a rapid assessment of the DNA microsatellite status in human colorectal cancer. , 2019, The Journal of molecular diagnostics : JMD.

[9]  T. Bosse,et al.  Incorporation of molecular characteristics into endometrial cancer management , 2019, Histopathology.

[10]  C. Gilks,et al.  Interpretation of somatic POLE mutations in endometrial carcinoma , 2019, The Journal of pathology.

[11]  Tae Won Kim,et al.  Clinical Utility of a Fully Automated Microsatellite Instability Test with Minimal Hands-on Time , 2019, Journal of pathology and translational medicine.

[12]  A. Scarpa,et al.  ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  F. Staroz,et al.  Microsatellite instability diagnosis using the fully automated Idylla platform: feasibility study of an in-house rapid molecular testing ancillary to immunohistochemistry in pathology laboratories , 2019, Journal of Clinical Pathology.

[14]  Xia Li,et al.  Evaluation of a Fully Automated Idylla Test System for Microsatellite Instability in Colorectal Cancer. , 2019, Clinical colorectal cancer.

[15]  Serena Wong,et al.  Minimal microsatellite shift in microsatellite instability high endometrial cancer: a significant pitfall in diagnostic interpretation , 2018, Modern Pathology.

[16]  K. Decanniere,et al.  Detection of microsatellite instability (MSI) with a novel set of 7 Idylla biomarkers on colorectal cancer samples in a multi-center study. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  R. Yantiss,et al.  Assessing colorectal cancer mismatch repair status in the modern era: a survey of current practices and re-evaluation of the role of microsatellite instability testing , 2018, Modern Pathology.

[18]  P. Goodfellow,et al.  Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer , 2018, JAMA oncology.

[19]  Ahmet Zehir,et al.  Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data. , 2017, JCO precision oncology.

[20]  R. Sanz-Pamplona,et al.  Molecular approaches for classifying endometrial carcinoma. , 2017, Gynecologic oncology.

[21]  Jay Shendure,et al.  Classification and characterization of microsatellite instability across 18 cancer types , 2016, Nature Medicine.

[22]  M. Morgan,et al.  Pembrolizumab in advanced endometrial cancer: Preliminary results from the phase Ib KEYNOTE-028 study. , 2016 .

[23]  A. Talhouk,et al.  A clinically applicable molecular-based classification for endometrial cancers , 2015, British Journal of Cancer.

[24]  Joshua M. Stuart,et al.  Integrated genomic characterization of endometrial carcinoma , 2013, Nature.

[25]  X. Matías-Guiu,et al.  Molecular pathology of endometrial carcinoma , 2013, Histopathology.

[26]  J. Shia.  Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. , 2008, The Journal of molecular diagnostics : JMD.

[27]  J. Shia,et al.  Utility of Immunohistochemistry in Predicting Microsatellite Instability in Endometrial Carcinoma , 2007, The American journal of surgical pathology.

[28]  S. Andrew,et al.  Microsatellite instability in endometrioid endometrial carcinoma: correlation with clinically relevant pathologic variables , 2005, International Journal of Gynecologic Cancer.

[29]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[30]  P. Peltomäki,et al.  Endometrial and colorectal tumors from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instability. , 2002, The American journal of pathology.

[31]  R. Eisenberg,et al.  Differences in Microsatellite Instability Profiles between Endometrioid and Colorectal Cancers: A Potential Cause for False-Negative Results? , 2017, The Journal of molecular diagnostics : JMD.

[32]  J. Boyd,et al.  Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer. , 2008, Human pathology.

[33]  R. Broaddus,et al.  Pathologic features of endometrial carcinoma associated with HNPCC , 2006, Cancer.